SiRNA induced cyclinb1 knockdown sensitizes hepg2 cells to daunorubicin

Progress in Biochemistry and Biophysics

Volumn 38, Issue 6, 2011, Pages 551-557

  Zhang, Yong ^a   Zu, Xu Yu ^a,b   Luo, Wei Shi ^a   Tang, Shen Song ^a   Jiang, Yu Yang ^b,c  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b TSINGHUA UNIVERSITY   (China)

^c Tsinghua University   (China)

Author keywords

Cyclinb1; Daunorubicin; Drug combinational effect; Drug resistance; SiRNA

Indexed keywords

EQUUS ASINUS;

EID: 79960225898     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00517     Document Type: Article

References (20)

1. Neuwald A, Hirano T. HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions. Genome Research, 2000, 10 (10): 1445-1453.
2. Dong Y, Sui L, Watanabe Y, et al. Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. Cancer letters, 2002, 177 (1): 13-19. (Pubitemid 34102394)
3. Hassan K, Ang K, El-Naggar A, et al. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Research, 2002, 62 (22): 6414-6421.
4. Takeno S, Noguchi T, Kikuchi R, et al. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer, 2002, 94 (11): 2874-2881. (Pubitemid 34547686)
5. Wang A YN, Ino N, Tanaka T, Mori H. Overexpression of cyclin B1 in human colorectal cancers. J Cancer Res Clin Oncol, 1997, 123(1): 124-127. (Pubitemid 27062538)
6. Nozoe T, Kabashima A, Ohga T, et al. Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res, 2002, (8): 817-822. (Pubitemid 34742113)
7. Banerjee SK, Zoubine MN, Campbell DR, et al. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associatedgastric MALT and MALT lymphoma: relationship tocell death, proliferation, and transformation. Am J Pathol, 2000, 156(2): 217-225. (Pubitemid 30644455)
8. Soria JC, Khuri FR, Hassan K, et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res, 2000, 60(9): 4000-4004. (Pubitemid 30636572)
9. Zhao M, Yoon BS, Kim SW, et al. Expression profiling of cyclin B1 and D1 in cervical carcinoma. Exp Oncol, 2006, 28(1): 44-48.
10. Hassan KA, El Naggar AK, Story MD, et al. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res, 2002, 62(12): 6414-6417. (Pubitemid 35364097)
11. Kawamoto H, Uchikoshi T. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. Am J Pathol, 1997, 150(1): 15-23. (Pubitemid 27027091)
12. Rudolph P, Alm P, Ferno M, et al. Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer. Int J Cancer, 2003, 105(3): 674-680. (Pubitemid 36687736)
13. Suzuki T, Miki Y, Moriya T, et al. Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor. Cancer Sci, 2007, 98(4): 644-651. (Pubitemid 46563439)
14. Yuan J, Krämer A, Eckerdt F, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human. Oncogene, 2004, 29(17): 5843-5852. (Pubitemid 39093030)
15. Zu X, Yan R, Robbins, S, et al. Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression. Toxicol Sci, 2007, 97(6): 562-568. (Pubitemid 47073870)
16. Yin XY, Grove L, Datta, N S, et al. Chromosomal Instability Induced by Pim-1 Is Passage-dependent and Associated with Dysregulation of Cyclin B1. Cancer Res, 2001, 61(17): 6487-6493.
17. Santana C OEaG-CA. Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner. Mutat Res, 2002, 508(1): 49-58.
18. MacLachlan TK, Sgagias M, Shifman Y, et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem, 2000, 275(9): 2777-2785. (Pubitemid 30082049)
19. Innocente SA, Cogswell JP, Lee JM. p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci U S A, 1999, 96(7): 2147-2152. (Pubitemid 29117882)
20. Androic I, Yan R, Rödel F, et al. Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol. BMC Cancer, 2008, 29: 391.